Standout Papers

Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer 2017 2026 2020 2023 1.4k
  1. Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer (2017)
    Karim Fizazi, Luis Fein et al. New England Journal of Medicine

Immediate Impact

1 by Nobel laureates 4 from Science/Nature 59 standout
Sub-graph 1 of 18

Citing Papers

Prostate Cancer
2025 Standout
Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer
2023 Standout
17 intermediate papers

Works of Mary B. Todd being referenced

Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer
2017 Standout
Prevalence of Prostate Cancer Clinical States and Mortality in the United States: Estimates Using a Dynamic Progression Model
2015
and 6 more

Author Peers

Author Last Decade Papers Cites
Mary B. Todd 2081 721 589 669 54 2.5k
De Phung 1668 604 482 601 46 2.0k
Susan Feyerabend 3080 974 977 1074 71 3.7k
Robert Given 1653 527 414 444 56 2.1k
Peter De Porre 2399 863 734 818 90 3.3k
Daniel H. Shevrin 2997 1154 1164 884 77 3.8k
Angela Lopez‐Gitlitz 1667 642 350 553 61 1.8k
Ivo Kocák 2416 926 1363 777 40 3.2k
Liji Shen 2728 1099 1240 921 35 3.4k
David Lorente 1806 643 1147 1041 100 2.8k
Diletta Bianchini 1617 749 650 751 67 2.1k

All Works

Loading papers...

Rankless by CCL
2026